Cycloserine
Cycloserine Capsules USP, 250 mg
Approved
Approval ID
8e7e2665-7a3d-3f54-9f92-5fe845f02ef9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 13, 2023
Manufacturers
FDA
Dr. Reddy’s Laboratories, Inc.
DUNS: 802315887
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cycloserine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code43598-235
Application NumberANDA060593
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cycloserine
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 13, 2023
FDA Product Classification
INGREDIENTS (1)
CYCLOSERINEActive
Quantity: 250 mg in 1 1
Code: 95IK5KI84Z
Classification: ACTIB